Saturday, 5 September 2026European Markets
ExploreSearch
ViaNews EU
Via News Knowledge File

SpaceX

organization80% conf.·synced Sep 5, 2026

Space company mentioned as only comparable entity to Planet Labs for scaled constellation capability

58
sourced metrics
1316
relationships
20
stated objectives
1
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Net Income
-1.5USD
Aug 4, 2026source
Stock Price
123.99USD
Jul 17, 2026source
Valuation
1.77trillion_USD
Jul 1, 2026source
Market Cap
1250000000000.0USD
Jul 1, 2026source
Ipo Proceeds
75USD
Jul 1, 2026source
Debt
360000000.0USD
Jun 27, 2026source
Shares Per 7000 Usd Investment
37.84shares
Jun 23, 2026source
Shares Per 1000 Usd Investment
5.41shares
Jun 23, 2026source
Shares Per 15000 Usd Investment
81.08shares
Jun 23, 2026source
Market Rank
5rank
Jun 16, 2026source
Ipo Retail Allocation Pct
30percent
Jun 13, 2026source
Market Share
6rank_us_listed_companies
Jun 13, 2026source
Ipo Demand
150USD
Jun 13, 2026source
Ipo Raise Target
75USD
Jun 13, 2026source
Ipo Indications Of Interest
250USD
Jun 12, 2026source
Retail Ipo Allocation
30percent
Jun 12, 2026source
Gdp
28.5trillion_USD_total_addressable_market
Jun 11, 2026source
Ipo Raise
75USD
Jun 11, 2026source

Stated objectives

Make humanity interplanetary to sustain consciousness

source
stated

Plan IPO at $1.5 trillion valuation

source
target: 1.5 trillion USD by 2026-01-01 00:00:00stated

IPO at $1.5 trillion valuation or potentially half that

source
target: 1.5 trillion USD by 2026-01-01 00:00:00stated

SpaceX plans to go public

source
target: 1.5 trillion USD valuation stated

IPO that would value company at $1.5 trillion

source
target: 1.5 trillion USD by 2026-01-01 00:00:00stated

Complete IPO and become publicly traded

source
by 2026-01-01 00:00:00stated

Go public through IPO in 2026 to unlock capital markets

source
by 2026-01-01 00:00:00stated

Achieve IPO valuation around $1.5 trillion

source
target: 1500000000000 stated

Target between 175 and 180 Falcon launches for 2025

source
target: 175-180 by 2025-12-31 00:00:00stated

Achieve IPO at $1.5 trillion valuation

source
target: 1.5 trillion USD by 2026-06-15 00:00:00stated

Relationship graph · 1316 connections

founded
160
Competes with
148
Developed by
143
Covered by
110
Employs
101
Invested in
98
Owns
89
Supplies to
59
acquired by
xAIxAI

Where sources disagree

We surface conflicts between sources rather than hiding them.

value conflictunresolved

The same attribute (net_income) for SpaceX has two different values (-541 USD vs -500 USD) observed at the identical timestamp (2026-08-04 00:00:00). A single financial metric cannot have two distinct values for the same period.

source Asource B

Via News coverage

While Silicon Valley Wrestles With Watermarks and Executive Exits, Two European AI Firms Bet on Efficiency Over Scale
August 19, 2026
This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com